CAMBRIDGE, Mass., April 9 -- CompuCyte Corp. has concluded a restructuring of its operations, allowing it to refocus on its successful line of laser scanning cytometers (LSCs). CompuCyte also reported the completion of a round of private financing, providing the company with $4 million in working capital. Additionally, the company is completing development of the next generation of its LSC product line. The new instrument, a fully automated laser scanning cytometer, uses an inverted measurement platform and database software that is well suited for arrays of high-content cell specimens such...Read full articleRelated content from Photonics Media